Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX).
暂无分享,去创建一个
C. Lepage | J. Taieb | R. Coriat | D. Malka | J. Bachet | K. Le Malicot | É. Terrebonne | M. Gouttebel | Y. Rinaldi | S. Louafi | L. Miglianico | A. Thirot Bidault | P. Texereau | F. Khemissa Akouz | H. Laharie | Anne-Laure Pointet | Bidaut Wahiba | A. Gratet | K. Bouhier Leporrier